Skip to main
IQV

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 40%
Buy 53%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings has demonstrated robust growth across its segments, particularly in Functional Service Provider (FSP), Real World Evidence (RWE), and Clinical Sales and Marketing Services (CSMS), all recording year-over-year growth in the third quarter. The company is experiencing improved client decision timelines and a strong pipeline, primarily fueled by recent drug launches, positioning it well for continued commercial momentum. Additionally, IQVIA's confidence in achieving over 4% growth in its Research & Development Services (R&DS) segment, coupled with an improved pricing environment allowing the company to optimize deal selection, underscores its positive financial outlook.

Bears say

The financial outlook for IQVIA Holdings reflects a concerning slowdown in year-over-year constant currency (CC) growth, declining from 6.8% in 2Q25 to 3.8% in 3Q25, particularly due to challenging comparisons from the prior year. Despite the company’s assertions of confidence regarding future revenue growth, the expectation of at least 5% growth in 2026, combined with operational challenges related to passthrough margins and increasing interest rates, could exert further pressure on earnings. Additionally, the disparate growth rates among segments, particularly the slower rates in the Technology and Analytics Services (TAS) and Research and Development Services (R&DS) segments, highlights potential vulnerabilities in sustaining overall revenue momentum.

IQVIA Hlds (IQV) has been analyzed by 15 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 53% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 15 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $234.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $234.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.